Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001123292-16-002653
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-09-07 17:22:48
Reporting Period:
2016-09-07
Filing Date:
2016-09-07
Accepted Time:
2016-09-07 17:22:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1076481 Sequenom Inc SQNM Services-Medical Laboratories (8071) DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
920148 Laboratory Corp Of America Holdings 358 South Main Street
Burlington NC 27215
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Acquisiton 2016-09-07 36,649,440 $2.40 119,551,297 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. These shares were acquired pursuant to an Agreement and Plan of Merger, dated July 26, 2016 (the "Merger Agreement"), by and among the Reporting Person, Savoy Acquisition Corp., a wholly owned subsidiary of the Reporting Person ("Purchaser"), and the Issuer. Pursuant to the Merger Agreement, the Reporting Person acquired all of the outstanding shares of the Issuer in a two-step transaction involving, first, the completion of a tender offer by the Reporting Person and Purchaser (the "Tender Offer"), and, second, a back-end merger for 100% ownership pursuant to which Purchaser merged with and into the Issuer and the Reporting Person acquired all of the outstanding shares of the Issuer that were not acquired by Purchaser in the Tender Offer. The acquired shares reported herein were acquired by the Reporting Person as part of the second step of the transaction.